Home Data Calendar Blog

AXNX

Tables

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 0.00 NA

Weighted Average Number Of Diluted Shares Outstanding 50.09 49.09 48.58 NA 47.21 45.31 45.14 NA 44.85 42.79 39.61 NA 38.83 36.44 NA NA NA NA NA NA NA NA NA NA NA

Weighted Average Number Of Shares Outstanding Basic 49.24 49.09 48.58 NA 47.21 45.31 45.14 NA 44.85 42.79 39.61 NA 38.83 36.44 NA NA NA NA NA NA NA NA NA NA NA

Earnings Per Share Basic 0.08 -0.15 -0.19 0.03 -0.34 -0.47 -0.50 -0.33 -0.38 -0.59 -0.57 -0.28 -0.24 -0.54 NA NA NA NA NA NA NA NA NA NA NA

Earnings Per Share Diluted 0.08 -0.15 -0.19 0.03 -0.34 -0.47 -0.50 -0.33 -0.38 -0.59 -0.57 -0.28 -0.24 -0.54 NA NA NA NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Revenue From Contract With Customer Excluding Assessed Tax 93.10 92.89 70.65 85.92 70.38 68.98 48.42 53.13 46.91 45.87 34.37 34.78 35.24 15.21 26.30 9.95 1.31 1.50 1.08 0.50 0.20 0.01 0.00 0.03 0.10

Revenues 93.10 92.89 70.65 85.92 70.38 68.98 48.42 53.13 46.91 45.87 34.37 34.78 35.24 15.21 26.30 9.95 1.31 1.50 1.08 0.50 0.20 0.01 0.00 0.03 0.10

Cost Of Goods And Services Sold 24.00 22.70 18.15 22.95 19.12 18.78 15.18 17.74 15.72 17.14 13.97 12.65 13.43 8.46 9.89 4.54 0.63 0.77 0.55 0.24 0.11 0.01 0.00 0.00 0.12

Gross Profit 69.10 70.19 52.50 62.97 51.26 50.20 33.24 35.39 31.19 28.73 20.40 22.13 21.81 6.75 16.40 5.41 0.68 0.72 0.53 0.25 0.10 0.01 0.00 0.00 0.01

Operating Expenses 69.79 82.26 66.87 66.58 67.64 71.62 56.77 53.07 47.70 44.74 42.02 33.01 30.58 26.16 31.11 28.07 25.72 19.99 14.15 9.70 7.64 8.62 6.53 4.94 4.60

Research And Development Expense 8.17 8.95 8.06 8.10 7.94 7.13 11.24 10.18 8.65 9.10 9.37 8.14 7.75 6.40 6.88 6.23 4.86 4.87 4.22 4.78 3.90 6.18 4.54 3.37 3.13

General And Administrative Expense 11.78 10.71 12.17 10.26 9.39 10.57 10.01 9.40 8.72 8.04 6.63 6.59 5.77 5.54 7.65 5.54 5.16 4.36 4.01 3.50 2.79 1.64 1.44 1.30 1.10

Selling And Marketing Expense 47.54 44.27 42.65 43.82 39.75 39.38 33.06 31.34 28.11 25.41 20.93 18.28 17.06 14.22 16.57 16.30 15.71 10.75 5.91 1.42 0.95 0.81 0.55 0.26 0.37

Operating Income Loss -0.69 -12.07 -14.37 -3.61 -16.38 -21.43 -23.53 -17.68 -16.50 -16.01 -21.62 -10.88 -8.77 -19.41 -14.71 -22.66 -25.05 -19.27 -13.62 -9.45 -7.54 -8.62 -6.53 -4.94 -4.59

Interest Paid Net 0.02 NA NA 0.00 0.00 0.00 0.00 0.00 0.00 2.01 0.17 0.25 0.26 0.26 0.33 0.34 0.37 0.37 0.36 0.36 0.19 0.17 0.04 0.00 NA

Allocated Share Based Compensation Expense 11.47 11.20 10.71 8.76 8.22 7.91 7.14 6.84 6.69 6.33 5.30 3.58 3.77 3.82 3.92 2.92 2.78 1.88 1.14 0.25 0.10 0.19 0.07 0.09 0.17

Income Tax Expense Benefit -0.43 -0.30 -0.81 -0.52 -0.52 -0.47 -1.11 -2.49 0.53 3.30 -0.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Income Taxes Paid Net 0.00 NA NA 0.02 0.01 NA NA 0.00 0.00 NA NA NA NA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA

Profit Loss 3.93 -7.34 -9.25 0.67 -16.25 -21.44 -22.67 -15.17 -17.25 -25.15 -22.50 -11.35 -9.17 -19.78 -14.62 -22.75 -25.01 -19.06 -13.12 -9.66 -7.57 -8.65 -6.60 -4.93 NA

Net Income Loss 3.93 -7.34 -9.25 0.67 -16.25 -21.44 -22.67 -15.17 -17.25 -25.15 -22.50 -11.35 -9.17 -19.78 -14.62 -22.75 -25.01 -19.06 -13.12 -9.66 -7.57 -8.65 -6.60 -4.93 -4.52

Comprehensive Income Net Of Tax -2.26 -3.59 -6.18 11.70 -28.31 -34.09 -27.59 -14.81 -22.39 -24.29 -24.70 -11.16 -9.07 -19.89 -14.79 -22.60 -25.12 -19.10 -13.13 -9.68 -7.57 -8.65 -6.61 -4.93 -4.00

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Assets 660.75 648.99 665.69 659.35 632.28 514.09 525.57 547.95 561.30 565.51 444.97 342.21 347.67 348.74 217.38 219.82 126.04 146.45 159.43 171.91 42.32 NA NA 29.41 NA

Liabilities 50.13 48.46 89.08 89.21 82.76 76.36 62.14 65.51 71.22 61.25 114.82 54.84 53.77 50.84 44.90 36.82 33.86 32.04 28.09 28.63 18.00 NA NA 2.54 NA

Liabilities And Stockholders Equity 660.75 648.99 665.69 659.35 632.28 514.09 525.57 547.95 561.30 565.51 444.97 342.21 347.67 348.74 217.38 219.82 126.04 146.45 159.43 171.91 42.32 NA NA 29.41 NA

Stockholders Equity 610.62 600.53 576.61 570.14 549.52 437.73 463.43 482.44 490.09 504.26 330.15 287.37 293.90 297.90 172.48 183.00 92.19 114.41 131.33 143.28 -88.88 -81.42 -72.96 -66.42 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Assets Current 475.38 455.40 469.67 465.07 449.36 313.13 307.43 321.32 330.23 332.18 228.37 327.95 334.46 335.50 204.06 211.68 117.82 138.02 152.80 165.34 35.34 NA NA 26.92 NA

Cash And Cash Equivalents At Carrying Value 147.32 145.34 240.10 238.85 241.33 203.24 213.18 220.88 228.80 231.14 130.96 241.18 269.28 287.68 159.82 171.08 76.23 82.68 89.33 98.31 20.15 NA NA 24.40 30.27

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 147.32 145.34 240.10 238.85 241.33 203.24 213.18 220.88 228.80 231.14 130.96 241.18 269.28 287.68 159.82 171.08 76.23 82.68 89.33 98.31 20.15 24.73 47.38 24.40 NA

Short Term Investments 197.39 186.17 116.96 118.36 108.68 10.00 NA NA NA NA NA NA NA 0.00 0.00 12.59 25.31 43.00 54.82 59.22 11.07 NA NA 0.00 NA

Accounts Receivable Net Current 48.94 47.44 40.20 44.82 36.96 36.12 27.43 29.04 26.64 25.65 21.51 18.27 17.65 14.12 20.77 7.88 0.95 1.29 0.80 0.43 0.22 NA NA 0.00 NA

Inventory Net 74.91 70.08 66.07 55.77 57.83 58.41 61.88 64.95 70.36 70.39 71.24 63.06 44.31 30.14 19.23 15.66 12.70 7.97 5.06 3.67 2.15 NA NA 1.54 NA

Prepaid Expense And Other Assets Current 6.82 6.36 6.34 7.28 4.56 5.37 4.95 6.45 4.43 5.01 4.66 5.43 3.22 3.57 4.25 4.47 2.62 3.07 2.78 3.72 1.75 NA NA 0.98 NA

Available For Sale Securities Debt Securities 197.39 186.17 116.96 118.36 NA NA NA NA NA NA NA NA NA 0.00 0.00 12.59 25.31 43.00 54.82 59.22 NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Property Plant And Equipment Gross 16.58 15.42 15.14 14.33 14.30 13.90 12.99 12.46 11.37 10.69 10.32 10.14 10.02 9.37 8.82 6.11 5.73 5.50 5.12 4.77 4.55 NA NA 2.68 NA

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 10.02 9.07 8.12 7.54 7.20 6.67 6.09 5.54 5.20 4.73 4.27 3.81 4.23 3.81 3.41 3.06 2.78 2.50 2.23 1.98 1.73 NA NA 1.15 NA

Amortization Of Intangible Assets 2.30 2.28 2.22 2.27 2.32 2.33 2.46 2.15 2.22 2.20 0.68 0.00 0.00 0.00 0.03 0.00 0.00 0.00 NA 0.00 0.00 NA NA 0.00 NA

Property Plant And Equipment Net 6.56 6.35 7.02 6.80 7.10 7.23 6.91 6.92 6.17 5.96 6.05 6.33 5.79 5.56 5.41 3.05 2.95 3.00 2.89 2.78 2.82 NA NA 1.53 NA

Goodwill 95.29 98.88 96.58 94.41 86.94 94.85 102.56 105.51 109.56 106.63 87.38 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Intangible Assets Net Excluding Goodwill 80.27 85.54 85.89 86.25 81.79 91.63 101.18 106.47 108.30 113.42 115.02 0.20 NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Assets Noncurrent 3.25 2.82 6.53 6.81 7.08 7.25 7.49 7.73 7.04 7.32 8.14 7.74 7.20 7.42 7.63 4.78 4.93 5.07 3.34 3.36 3.71 NA NA 0.42 NA

Available For Sale Debt Securities Amortized Cost Basis 197.43 186.21 116.99 118.48 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Liabilities Current 35.59 32.08 66.17 65.25 60.84 29.86 25.52 26.87 27.75 24.39 24.05 45.68 38.82 30.83 19.85 12.03 15.54 11.30 6.69 5.89 5.50 NA NA 2.40 NA

Accounts Payable Current 14.67 12.19 14.74 9.07 9.97 10.21 10.39 7.65 10.51 9.45 11.45 10.66 9.41 10.73 7.44 5.88 4.23 3.19 2.10 3.44 1.98 NA NA 1.62 NA

Accrued Liabilities Current 5.96 5.57 6.64 6.52 7.11 7.30 6.25 5.43 6.42 6.30 5.87 6.68 5.98 3.96 3.11 2.17 4.30 3.63 2.36 1.68 2.71 NA NA 0.79 NA

Other Liabilities Current NA NA 34.40 32.60 30.50 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Deferred Income Tax Liabilities Net 13.66 15.17 15.74 16.41 13.96 15.78 17.56 19.22 26.43 20.63 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Other Liabilities Noncurrent NA NA NA NA NA 22.40 10.37 10.37 8.88 7.66 6.75 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Operating Lease Liability Noncurrent 0.88 1.20 7.18 7.55 7.96 8.32 8.69 9.05 8.15 8.48 8.85 9.15 9.03 9.26 9.48 4.45 4.57 4.74 3.48 3.28 3.45 NA NA 0.14 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Stockholders Equity 610.62 600.53 576.61 570.14 549.52 437.73 463.43 482.44 490.09 504.26 330.15 287.37 293.90 297.90 172.48 183.00 92.19 114.41 131.33 143.28 -88.88 -81.42 -72.96 -66.42 NA

Common Stock Value 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 0.00 NA

Additional Paid In Capital 1022.05 1009.70 982.19 969.54 960.63 820.53 812.14 803.56 796.40 788.18 589.78 522.30 517.66 512.59 367.28 363.01 249.60 246.71 244.52 243.34 3.34 NA NA 2.90 NA

Retained Earnings Accumulated Deficit -386.93 -390.85 -383.51 -374.26 -374.93 -358.68 -337.23 -314.57 -299.40 -282.15 -257.00 -234.50 -223.15 -213.98 -194.20 -179.58 -156.83 -131.83 -112.77 -99.65 -89.98 NA NA -67.17 NA

Accumulated Other Comprehensive Income Loss Net Of Tax -24.51 -18.33 -22.08 -25.15 -36.19 -24.13 -11.48 -6.56 -6.91 -1.77 -2.63 -0.43 -0.61 -0.71 -0.60 -0.43 -0.58 -0.47 -0.43 -0.42 -0.41 NA NA -0.40 NA

Stock Issued During Period Value New Issues NA NA NA NA 128.31 NA NA NA NA 189.98 NA NA NA 140.49 NA NA NA NA NA NA NA NA NA NA NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Net Cash Provided By Used In Operating Activities 12.34 -19.21 -0.78 9.35 3.85 -0.84 -9.17 -6.78 -2.99 -11.95 -25.58 -28.31 -19.15 -12.97 -23.31 -28.14 -23.90 -18.36 -13.05 -9.30 -8.10 -7.35 -6.62 -5.33 NA

Net Cash Provided By Used In Investing Activities -11.05 -68.62 0.69 -10.03 -99.40 -10.63 -0.29 -1.08 -0.68 -0.37 -140.86 -1.02 -0.65 -0.55 11.88 12.34 17.46 11.44 4.05 -48.12 3.52 -15.29 -0.16 -0.55 NA

Net Cash Provided By Used In Financing Activities 0.88 -6.77 1.93 0.16 131.88 0.48 1.44 0.20 1.52 112.57 56.22 1.05 1.30 141.50 0.34 110.49 0.11 0.31 0.04 135.58 0.01 0.00 29.76 0.00 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Net Cash Provided By Used In Operating Activities 12.34 -19.21 -0.78 9.35 3.85 -0.84 -9.17 -6.78 -2.99 -11.95 -25.58 -28.31 -19.15 -12.97 -23.31 -28.14 -23.90 -18.36 -13.05 -9.30 -8.10 -7.35 -6.62 -5.33 NA

Net Income Loss 3.93 -7.34 -9.25 0.67 -16.25 -21.44 -22.67 -15.17 -17.25 -25.15 -22.50 -11.35 -9.17 -19.78 -14.62 -22.75 -25.01 -19.06 -13.12 -9.66 -7.57 -8.65 -6.60 -4.93 -4.52

Profit Loss 3.93 -7.34 -9.25 0.67 -16.25 -21.44 -22.67 -15.17 -17.25 -25.15 -22.50 -11.35 -9.17 -19.78 -14.62 -22.75 -25.01 -19.06 -13.12 -9.66 -7.57 -8.65 -6.60 -4.93 NA

Depreciation Depletion And Amortization 3.25 3.23 2.81 2.88 2.92 2.89 3.03 2.64 2.69 2.66 1.13 0.49 0.45 0.43 0.38 0.31 0.31 0.29 0.28 0.28 0.23 0.21 0.21 0.21 NA

Increase Decrease In Accounts Receivable 1.61 7.23 -4.67 7.75 0.96 8.86 -1.59 2.33 1.08 4.11 1.48 0.62 3.41 -6.66 13.40 7.00 -0.33 0.48 0.38 0.21 0.20 0.01 0.00 -0.06 NA

Increase Decrease In Inventories 4.85 4.36 10.12 -2.17 -0.04 -3.21 -3.02 -5.56 0.12 -0.65 7.19 18.75 14.17 10.86 3.57 2.96 4.73 2.91 1.39 1.65 0.23 0.07 0.30 0.73 NA

Increase Decrease In Accounts Payable 2.61 -2.62 5.59 -1.05 0.36 -0.38 2.53 -2.92 1.15 -2.00 0.91 1.25 -1.31 3.29 1.56 1.65 1.68 0.45 -1.33 1.45 -0.10 0.62 -0.15 0.49 NA

Share Based Compensation 11.47 11.20 10.71 8.76 8.22 7.91 7.14 6.84 6.69 6.33 5.30 3.58 3.77 3.82 3.92 2.92 2.78 1.88 1.14 0.25 0.10 0.19 0.07 0.09 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Net Cash Provided By Used In Investing Activities -11.05 -68.62 0.69 -10.03 -99.40 -10.63 -0.29 -1.08 -0.68 -0.37 -140.86 -1.02 -0.65 -0.55 11.88 12.34 17.46 11.44 4.05 -48.12 3.52 -15.29 -0.16 -0.55 NA

Payments To Acquire Property Plant And Equipment 1.19 0.26 0.79 0.34 0.96 0.63 0.29 1.08 0.68 0.37 0.12 1.02 0.65 0.55 0.71 0.38 0.23 0.38 0.35 0.22 0.71 0.14 0.16 0.55 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Net Cash Provided By Used In Financing Activities 0.88 -6.77 1.93 0.16 131.88 0.48 1.44 0.20 1.52 112.57 56.22 1.05 1.30 141.50 0.34 110.49 0.11 0.31 0.04 135.58 0.01 0.00 29.76 0.00 NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30

Revenues 93.10 92.89 70.65 85.92 70.38 68.98 48.42 53.13 46.91 45.87 34.37 34.78 35.24 15.21 26.30 9.95 1.31 1.50 1.08 0.50 0.20 0.01 0.00 0.03 0.10

Bulkamid 19.15 18.71 15.49 15.61 13.53 13.22 9.35 8.71 6.84 5.67 1.47 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation 73.95 74.19 55.16 70.30 56.86 55.76 39.07 44.42 40.07 40.19 32.90 34.78 35.24 15.21 26.30 NA NA NA NA NA NA NA NA NA NA

Bulkamid,US 15.58 14.81 11.61 12.34 11.04 10.22 6.57 5.79 3.92 2.37 0.58 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Bulkamid, Non Us 3.57 3.90 3.88 3.27 2.48 3.00 2.78 2.92 2.92 3.30 0.89 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation,US 72.21 72.20 53.85 69.07 55.61 54.47 37.72 43.70 39.15 39.24 31.75 33.71 34.14 NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation, Non Us 1.74 1.98 1.30 1.24 1.25 1.29 1.35 0.72 0.92 0.95 1.16 1.07 1.10 NA NA NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 93.10 92.89 70.65 85.92 70.38 68.98 48.42 53.13 46.91 45.87 34.37 34.78 35.24 15.21 26.30 9.95 1.31 1.50 1.08 0.50 0.20 0.01 0.00 0.03 0.10

Bulkamid 19.15 18.71 15.49 15.61 13.53 13.22 9.35 8.71 6.84 5.67 1.47 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation 73.95 74.19 55.16 70.30 56.86 55.76 39.07 44.42 40.07 40.19 32.90 34.78 35.24 15.21 26.30 NA NA NA NA NA NA NA NA NA NA

Bulkamid,US 15.58 14.81 11.61 12.34 11.04 10.22 6.57 5.79 3.92 2.37 0.58 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Bulkamid, Non Us 3.57 3.90 3.88 3.27 2.48 3.00 2.78 2.92 2.92 3.30 0.89 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation,US 72.21 72.20 53.85 69.07 55.61 54.47 37.72 43.70 39.15 39.24 31.75 33.71 34.14 NA NA NA NA NA NA NA NA NA NA NA NA

Sacral Neuromodulation, Non Us 1.74 1.98 1.30 1.24 1.25 1.29 1.35 0.72 0.92 0.95 1.16 1.07 1.10 NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Comprehensive Income Net Of Tax

Expenses

Income Tax Expense Benefit

Balance Sheet

Operating Lease Right Of Use Asset

Assets

Operating Lease Right Of Use Asset

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Operating Lease Right Of Use Asset

PropertyPlantAndEquipmentNet

Property Plant And Equipment Net

Liabilities

Operating Lease Liability

Current Liabilities

Operating Lease Liability Current

Noncurrent Liabilities

Operating Lease Liability Noncurrent

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInOperatingActivities

Increase Decrease In Accounts Receivable

NetCashProvidedByUsedInInvestingActivities

Net Cash Provided By Used In Investing Activities

Shares

Weighted Average Number Of Shares Outstanding Basic

OperatingLeaseLiability

Operating Lease Liability Noncurrent

NonoperatingIncomeExpense

Other Nonoperating Income Expense

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Undiscounted Excess Amount

InventoryNet

Inventory Work In Process Net Of Reserves

AccountsReceivable

Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept

TTM Greenblatt ROC
_
(None,)

T T M Greenblatt R O C_

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)

Allocated Share Based Compensation Expenseus-gaap: Income Statement Location

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)

Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
(None, 'us-gaap:FairValueMeasurementsRecurring')

Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)

Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)

Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)

Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
(None,)

Finite Lived Intangible Assets Netus-gaap: Finite Lived Intangible Assets By Major Class

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)

Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

Stockholders Equityus-gaap: Statement Equity Components

us-gaap:Revenues
us-gaap:ProductOrService
(None,)

Revenuesus-gaap: Product Or Service

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service